Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.

Clinical trial NCT00705588 · UNKNOWN

Trial details

NCT number: NCT00705588
Sponsor: Rabin Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2008-08-01
Primary completion: 2010-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.